Neuroleptic malignant syndrome. Beneficial effects of dantrolene on hyperthermia and hypertonia
De Rohan Chabot, P.; Elkharrat, D.; Conso, F.; Bismuth, C.; Goulon, M.
La Nouvelle Presse Medicale 11(14): 1067-1069
1982
ISSN/ISBN: 0301-1518 PMID: 7079122 Document Number: 196807
Document emailed within 1 workday
Related Documents
Schulte-Sasse, U.; Tarnow, J.; Eberlein, H.J. 1982: Successful treatment of malignant hyperthermia with dantrolene-sodium and uneventful re-anaesthesia after oral dantrolene-prophylaxis Der Anaesthesist 31(5): 241-244Cooper, J.M.; Jones, H.R.; Williamson, J.W. 1983: Treatment of malignant hyperthermia with dantrolene Journal of the Mississippi State Medical Association 24(10): 259-261
Gronert, G.A.; Thompson, R.L.; Onofrio, B.M. 1980: Human malignant hyperthermia: awake episodes and correction by dantrolene Anesthesia and Analgesia 59(5): 377-378
Alitalo, I.; Schulman, A. 1983: Halothane induced porcine malignant hyperthermia reversed by dantrolene Nordisk Veterinaermedicin 35(5-6): 239-242
Adnet, P.; Krivosic-Horber, R.; Guevart, E.; Theunynck, D.; Vincent, A. 1986: Experimental study of dantrolene sodium in anesthetic malignant hyperthermia in the pietrain-strain pig Cahiers d'Anesthesiologie 34(6): 463-467
Hara, Y.; Kato, A.; Horikawa, H.; Kato, Y.; Ichiyanagi, K. 1988: Postoperative respiratory depression thought to be due to oral dantrolene pretreatment in a malignant hyperthermia-susceptible patient Masui. Japanese Journal of Anesthesiology 37(4): 483-487
Lavie, C.J.; Olmsted, T.R.; Ventura, H.O.; Lepler, B.J. 1986: Neuroleptic malignant syndrome. An underdiagnosed reaction to neuroleptic agents? Postgraduate Medicine 80(3): 171-178
Larach, M.G.; Landis, J.R.; Bunn, J.S.; Diaz, M. 1992: Prediction of malignant hyperthermia susceptibility in low-risk subjects. An epidemiologic investigation of caffeine halothane contracture responses. The North American Malignant Hyperthermia Registry Anesthesiology 76(1): 16-27
Fernández, M.; Lago, L.; Alonso, M.Gema.; Guede, A.; Benavente, J.Luis.; Olivares, J.M. 2018: Serotonin syndrome versus neuroleptic malignant syndrome: a case report Actas Espanolas de Psiquiatria 46(2): 68-74
Courtine, J.C.; Blot, P. 1981: Malignant neuroleptic syndrome La Nouvelle Presse Medicale 10(21): 1749
Kishida, I.; Furuno, T.; Kawanishi, C. 2012: Neuroleptic malignant syndrome (NMS) Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 6): 612-615
Bidzińska, E. 1986: Malignant neuroleptic syndrome Psychiatria Polska 20(6): 483-488
Segado Soriano, A.; López Gonzalez-Cobos, C.; Villalba Garciá, M.V.; Gil Gómez, J.; Muiño Miguez, A.; Millan Núñez-Cortés, J. 1997: Malignant neuroleptic syndrome Anales de Medicina Interna 14(5): 231-235
Kimsey, L.R.; Gibbs, J.T.; Glen, R.S.; Markette, J.R.; Kosted, E. 1983: The neuroleptic malignant syndrome Texas Medicine 79(10): 54-55
Johannessen, J.O.; Bergrem, H. 1989: Neuroleptic malignant syndrome Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 109(6): 696-697
Suchanová, L. 1985: Malignant neuroleptic syndrome Ceskoslovenska Psychiatrie 81(2): 91-95
Müller, T.; Becker, T.; Fritze, J. 1989: Neuroleptic malignant syndrome Deutsche Medizinische Wochenschrift 114(11): 442-443
Till, E.; Vucković, S.; Lisulov, R.; Nedić, A. 1989: The neuroleptic malignant syndrome Medicinski Pregled 42(11-12): 419-423
Vallance, H.; McConachie, I. 1993: Neuroleptic malignant syndrome and ECT British Journal of Hospital Medicine 49(1): 50
Martínez, E.; Domingo, P.; Lloret, J. 1994: Malignant neuroleptic syndrome Medicina Clinica 102(5): 181-188